Patents by Inventor Robert Sabin

Robert Sabin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070032393
    Abstract: The invention provides rinse-off wet skin compositions comprising structuring systems which in turn comprise (a) non-pre-gelatinized starch; and (b) fatty acid, and which systems provide enhanced properties. The fatty acid also needs to be added to the aqueous phase during preparation of the formulation.
    Type: Application
    Filed: August 4, 2005
    Publication date: February 8, 2007
    Inventors: Rajesh Patel, Robert Sabin, Rosa Paredes
  • Publication number: 20060159649
    Abstract: The invention relates to wet skin treatment compositions having specific gum and acrylate dispersion stabilizer systems providing enhanced rheology (e.g., lotion-like rheology and spreadability) relative to other wet skin compositions.
    Type: Application
    Filed: January 14, 2005
    Publication date: July 20, 2006
    Inventors: Robert Sabin, Rosa Paredes, Philip Miner, Stephen Barrow, Jeffrey Wolcheski
  • Publication number: 20060147512
    Abstract: This disclosure relates to a Composition having medicinal properties for use with mammalian diseases such as anti-cancer properties and methods of use, anti-viral properties and methods of use, anti-protozoan properties and methods of use, and anti-bacterial properties and methods of use in mammals. A chemical Composition for use as a pharmaceutical of a biologically acceptable copper compound and may include other components such as iron, which is transported to afflicted cells in a pharmaceutical acceptable carrier.
    Type: Application
    Filed: July 29, 2005
    Publication date: July 6, 2006
    Inventor: Robert Sabin
  • Publication number: 20060008535
    Abstract: An anti-cancer composition having biocompatible materials, which can selectively exploit chemical variations between normal cells and cancer cells to inhibit or prevent the proliferation of cancerous cells and methods of use.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 12, 2006
    Inventor: Robert Sabin
  • Patent number: 5956764
    Abstract: A garment is provided for aerodynamic assistance or propulsion of a rider-propelled wheeled vehicle comprising sail-like extensions extending from the abdominal portion of the garment and secured at a point between the hand and about the elbow of the rider while gripping the handle bars of the vehicle.
    Type: Grant
    Filed: April 22, 1997
    Date of Patent: September 28, 1999
    Inventor: Robert Sabin
  • Patent number: 5873131
    Abstract: A garment is provided for aerodynamic assistance or propulsion of a rider-propelled wheeled vehicle comprising sail-like extensions extending from the abdominal portion of the garment and secured at the hand of the rider while gripping the handle bars of the vehicle.
    Type: Grant
    Filed: August 23, 1996
    Date of Patent: February 23, 1999
    Inventor: Robert Sabin
  • Patent number: 5593672
    Abstract: A method is provided for increasing and maintaining the quantity and activity of immune leukocyte effector cells in preparation for lymphokine and cytokine administration before and during treatment for disease pathogens. The method simultaneously up-regulates the expression of high affinity IL-2 receptors on the above mentioned cells, making them receptive to subsequent IL-2 administration, which activates and directs these cells to mediate cytotoxic activity against disease pathogens. The method may also be employed in conjunction with the administration of other lymphokines, cytokines, biological response modifiers and pharmacological compounds whose activity would benefit from an increase in effector cells. The preferred method of administration is by inhalation of a zinc oxide fume or particulate from 15 to 900 mg ZnO/m.sup.3 for one or more exposures per day, one hour or less per exposure.
    Type: Grant
    Filed: October 17, 1994
    Date of Patent: January 14, 1997
    Inventor: Robert Sabin
  • Patent number: 5217959
    Abstract: A method is provided for treating multiple sclerosis by administering to a subject afflicted with that disease a symptom-alleviating amount of a compound selected from the group consisting of phytic acid, mixed counterion phytate salt, an isomer or hydrolysate of phytic acid or mixed counterion phytate salt, a mixture of any combination thereof, or with one or more dephosphorylating enzymes. The preferred method of administration is by oral dosages of about 1/2 to 3 grams/kilogram bodyweight per day.
    Type: Grant
    Filed: September 6, 1990
    Date of Patent: June 8, 1993
    Inventor: Robert Sabin
  • Patent number: 5206226
    Abstract: A method is provided for treating Parkinson's Disease by administering to a subject an effective symptom-alleviating amount of a compound selected from the group consisting of phytic acid, phytate salt, an isomer or hydrolysate of phytic acid or phytate salt, or a mixture of any combination thereof. The preferred method of administration is by oral dosages of about 1/8 to 1/2 grams/kilogram bodyweight per day.
    Type: Grant
    Filed: December 13, 1991
    Date of Patent: April 27, 1993
    Inventor: Robert Sabin
  • Patent number: 5112814
    Abstract: A method is provided for treating Parkinson's Disease by administering to a subject an effective symptom-alleviating amount of a compound selected from the group consisting of phytic acid, phytate salt, an isomer or hydrolysate of phytic acid or phytate salt, or a mixture of any combination thereof. The preferred method of administration is by oral dosages of about 1/8 to 1/2 grams/kilogram bodyweight per day.
    Type: Grant
    Filed: October 24, 1990
    Date of Patent: May 12, 1992
    Inventor: Robert Sabin
  • Patent number: 4952396
    Abstract: A method is provided for inhibiting tumor growth by administering to a subject an effective tumor-inhibiting amount of a compound selected from the group consisting of phytic acid, phytate salt, an isomer or hydrolysate of phytic acid or phytate salt, or a mixture of any combination thereof. The preferred method of administration is by oral dosages of about 2 to 4 grams/kilogram bodyweight per day.
    Type: Grant
    Filed: June 10, 1988
    Date of Patent: August 28, 1990
    Assignees: Linus Pauling Institute of Science & Medicine, Robert Sabin
    Inventors: Robert Sabin, Raxit Jariwalla, Stephen Lawson
  • Patent number: 4847082
    Abstract: A method is provided for treating Alzheimer's Disease by administering to a subject an effective symptom-alleviating amount of a compound selected from the group consisting of phytic acid, phytate salt, an isomer or hydrolysate of phytic acid or phytate salt, or a mixture of any combination thereof. The preferred method of administration is by oral dosages of about 1/2 to 3 grams/kilogram bodyweight per day.
    Type: Grant
    Filed: April 5, 1988
    Date of Patent: July 11, 1989
    Assignee: Robert Sabin
    Inventor: Robert Sabin
  • Patent number: 4758430
    Abstract: A method is provided for treating Alzheimer's Disease by administering to a subject an effective symptom-alleviating amount of a compound selected from the group consisting of phytic acid, phytate salt, an isomer or hydrolysate of phytic acid or phytate salt, or a mixture of any combination thereof. The preferred method of administration is by oral dosages of about 1/2 to 3 grams/kilogram bodyweight per day.
    Type: Grant
    Filed: January 21, 1987
    Date of Patent: July 19, 1988
    Inventor: Robert Sabin